General Information
Revision date
2014-04-18
Product name
CAB-O-SIL M-5DP Untreated Fumed Silica
Product Synonyms
Untreated Fumed Silica, Silicon Dioxide, Synthetic Amorphous Silica, Pyrogenic (Fumed) Amorphous Silica, Colloidal Silicon Dioxide, Colloidal Anhydrous Silica, Light Anhydrous Silicic Acid Rheological control, Flow agent, Reinforcing agent in: Coatings, Adhesives, Various
CAS No.
112945-52-5
1.2.1 Relevant identified uses
Rheological control, Flow agent, Reinforcing agent in: Coatings, Adhesives, Various
supplier name
Cabot GmbH
Emergency telephone
(+49) 7623.7070, 1-217-253-3370, 1-978-663-3455, (+49) 7623.707 530, (+44) 1446.736999, 1-217-253-5586, 1-978-670-6955, (+44) 1446.737123, 1-613-996-6666, (+49) 7623-7070, (+44) 1446-709 641, 1-800-424-9300, 1-703-527-3887
Icons in SDS
Company Information
company name
Cabot GmbH
GHS Information
Signal word
Not applicable
Section 2
SECTION 2: Hazards identification
Hazard statements
Not a hazardous substance or mixture according to the Globally Harmonized System (GHS) Not applicable
Hazard pictograms
Not applicable
Signal word
Not applicable
Precautionary statements
Not applicable EMERGENCY OVERVIEW - White powder. Odorless. Dust may be irritating to eyes and respiratory tract. CAUTION Repeated exposure may cause skin dryness or cracking. Take precautionary measures against static discharges. All metal parts of the mixing and processing equipment must be earthed/grounded. Ensure all equipment is electrically earthed/grounded before beginning transfer operations.
Principle Routes of Exposure
Inhalation, Skin contact, Eye contact
Potential health effects
Eye Contact Skin Contact Inhalation May cause mechanical irritation. Repeated exposure may cause skin dryness or cracking. Dust may be irritating to respiratory tract. Provide appropriate exhaust ventilation at machinery and at places where dust can be generated. See also Section 8. Ingestion Health injuries are not known or expected under normal use. Carcinogenic Effects Does not contain any substances greater than 0.1% listed by IARC (International Agency for Research on Cancer), NTP (National Toxicology Program), OSHA (Occupational Safety and Health Administration), ACGIH (American Conference for Governmental Industrial Hygienists) or EU (European Union). See also Section 11. Target Organ Effects Lungs
Medical Conditions Generally Aggravated by Exposure
Asthma, Respiratory disorder by Exposure
Environmental effects
No special environmental precautions required.
